Todd Harris
Founder at TYRA BIOSCIENCES, INC.
Net worth: 23 M $ as of 2024-04-29
Profile
Todd J.
Harris is the founder of Tyra Biosciences, Inc. (founded in 2018) and Sienna Biopharmaceuticals, Inc. (founded in 2010).
He is currently the President, CEO, Treasurer & Director at Tyra Biosciences, Inc. and the Director & Head-Corporate Development at Sienna Biopharmaceuticals, Inc. Additionally, Dr. Harris is currently working as a Director at Primmune Therapeutics, Inc. since 2019.
Dr. Harris has a doctorate degree from the Massachusetts Institute of Technology, an undergraduate degree from Brigham Young University, and a graduate degree from the University of California San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
2.86% | 2024-03-25 | 1,504,577 ( 2.86% ) | 23 M $ | 2024-04-29 |
Todd Harris active positions
| Companies | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Founder | 2018-08-01 |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Director/Board Member | 2019-09-30 |
Former positions of Todd Harris
| Companies | Position | End |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Founder | 2018-06-30 |
Training of Todd Harris
| Brigham Young University | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Todd Harris
